Cargando…

Deescalating Adjuvant Trastuzumab in HER2-Positive Early-Stage Breast Cancer: A Systemic Review and Meta-Analysis

BACKGROUND: One year of adjuvant trastuzumab in combination with chemotherapy is the standard of care in early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer. Existing data on shortening trastuzumab treatment show conflicting results. METHODS: A search of PubMed and abs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldvaser, Hadar, Korzets, Yasmin, Shepshelovich, Daniel, Yerushalmi, Rinat, Sarfaty, Michal, Ribnikar, Domen, Thavendiranathan, Paaladinesh, Amir, Eitan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649709/ https://www.ncbi.nlm.nih.gov/pubmed/31360906 http://dx.doi.org/10.1093/jncics/pkz033

Ejemplares similares

Efficacy and Safety of the Addition of Internal Mammary Irradiation to Standard Adjuvant Radiation in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis
por: Korzets, Yasmin, et al.
Publicado: (2022)

Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer
por: Mutai, Raz, et al.
Publicado: (2021)

The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer
por: Korzets, Yasmin, et al.
Publicado: (2021)

Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review
por: Porta‐Sánchez, Andreu, et al.
Publicado: (2017)

Efficacy, safety and tolerability of drugs studied in phase 3 randomized controlled trials in solid tumors over the last decade
por: Ribnikar, Domen, et al.
Publicado: (2021)

Efficacy and safety of trastuzumab emtansine (T-DM1) in the treatment of HER2-positive metastatic breast cancer (MBC): a meta-analysis of randomized controlled trial
por: Yan, Hongjing, et al.
Publicado: (2017)

Associations between safety, tolerability, and toxicity and the reporting of health‐related quality of life in phase III randomized trials in common solid tumors
por: Saleh, Ramy R., et al.
Publicado: (2020)

Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis
por: Reinhorn, Daniel, et al.
Publicado: (2021)

The concordance of treatment decision guided by OncotypeDX and the PREDICT tool in real‐world early‐stage breast cancer
por: Goldstein, Daniel A., et al.
Publicado: (2020)

The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics
por: Goldvaser, Hadar, et al.
Publicado: (2016)

Risk of hepatotoxicity with trastuzumab emtansine in breast cancer patients: a systematic review and meta-analysis
por: Cobert, Amani M., et al.
Publicado: (2020)

Dual HER2 Blockade in Neoadjuvant Treatment of HER2+ Breast Cancer: A Meta-Analysis and Review
por: Wang, Chaokun, et al.
Publicado: (2020)

COVID-19 in a patient receiving adjuvant breast cancer chemotherapy with granulocyte olony-stimulating factor (G-CSF) support: A case report
por: Yerushalmi, Rinat, et al.
Publicado: (2021)

Impact of Extended and Restricted Antibiotic Deescalation on Mortality
por: Teh, Hwei Lin, et al.
Publicado: (2021)

Efficacy of magnesium sulfate as an adjuvant to rocuronium in general anaesthesia: a meta-analysis
por: Sun, Haiyan, et al.
Publicado: (2021)

Regional myocardial edema detected by T2 mapping is a feature of cardiotoxicity in breast cancer patients receiving sequential therapy with anthracyclines and trastuzumab
por: Thavendiranathan, Paaladinesh, et al.
Publicado: (2014)

Prognostic value of HER-2/neu expression in epithelial ovarian cancer: a systematic review and meta-analysis
por: Wang, Kai, et al.
Publicado: (2017)

Efficacy and safety of neoadjuvant therapy for HER2-positive early breast cancer: a network meta-analysis
por: Zhang, Jie, et al.
Publicado: (2021)

The association between HER2-low expression and prognosis of breast cancer: a systematic review and meta-analysis
por: Tang, Yuyao, et al.
Publicado: (2023)

Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis
por: Burgos, Miguel, et al.
Publicado: (2022)

Utility of ctDNA in predicting relapse in solid tumors after curative therapy: a meta-analysis
por: Mittal, Abhenil, et al.
Publicado: (2023)

Ursodeoxycholic acid as adjuvant treatment to phototherapy for neonatal hyperbilirubinemia: a systematic review and meta-analysis
por: Kuitunen, Ilari, et al.
Publicado: (2022)

Adjuvant Efficacy of Nutrition Support During Pulmonary Tuberculosis Treating Course: Systematic Review and Meta-analysis
por: Si, Zhuang-Li, et al.
Publicado: (2015)

Clinical efficacy of platelet-rich plasma as adjuvant therapy in patients undergoing arthroscopic repair of meniscal injury
por: Wang, Yaodong, et al.
Publicado: (2020)

Adjuvant Chemotherapy for Advanced Gastric Cancer in Elderly and Non-elderly Patients: Meta-Analysis of Randomized Controlled Trials
por: Chang, Seong-Hwan, et al.
Publicado: (2017)

Survival and time to initiation of adjuvant chemotherapy among breast cancer patients: a systematic review and meta-analysis
por: Zhan, Qiao-Hui, et al.
Publicado: (2017)

Dexmedetomidine as an adjuvant for single spinal anesthesia in patients undergoing cesarean section: a system review and meta-analysis
por: Shen, Qi-hong, et al.
Publicado: (2020)

Adjuvant denosumab in early breast cancer: a systematic review and meta-analysis of randomized controlled clinical trials
por: Mastrantoni, Luca, et al.
Publicado: (2023)

Axillary Downstaging and the Impact of Clinical Axillary Status on Efficacy of Neoadjuvant Therapy for HER2-Positive Breast Cancer: A Network Meta-Analysis
por: Luo, Yunzhao, et al.
Publicado: (2023)

The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients
por: Ding, Yuqin, et al.
Publicado: (2023)

Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials
por: Kim, Hyung Suk, et al.
Publicado: (2017)

Dexmedetomidine versus magnesium sulfate as an adjuvant to local anesthetics in spinal anesthesia: a meta-analysis of randomized controlled trials
por: Wang, Jinguo, et al.
Publicado: (2020)

Neuraxial adjuvants for prevention of perioperative shivering during cesarean section: A network meta-analysis following the PRISMA guidelines
por: Zhang, Yi-Wei, et al.
Publicado: (2019)

The association of comorbidities with administration of adjuvant chemotherapy in stage III colon cancer patients: a systematic review and meta-analysis
por: Boakye, Daniel, et al.
Publicado: (2021)

Efficacy and Toxicity of Adjuvant Therapies for High-Risk Endometrial Cancer in Stage I–III: A Systematic Review and Network Meta-Analysis
por: Ao, Mengyin, et al.
Publicado: (2020)

Surrogate endpoint for overall survival in assessment of adjuvant therapies after curative treatment for hepatocellular carcinoma: a re-analysis of meta-analyses of individual patients’ data
por: Huan, Hong-Bo, et al.
Publicado: (2017)

Comparison of efficacy and tolerability of adjuvant therapy for resected high-risk stage III-IV cutaneous melanoma: a systemic review and Bayesian network meta-analysis
por: Ba, He, et al.
Publicado: (2023)

Evaluation of Risk Prediction Models to Identify Cancer Therapeutics Related Cardiac Dysfunction in Women with HER2+ Breast Cancer
por: Suntheralingam, Sivisan, et al.
Publicado: (2022)

Statin Exposure and Risk of Heart Failure After Anthracycline‐ or Trastuzumab‐Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study
por: Abdel‐Qadir, Husam, et al.
Publicado: (2021)

Systematic Review and Meta-analysis of Genetically Informed Research: Associations Between Parent Anxiety and Offspring Internalizing Problems
por: Ahmadzadeh, Yasmin I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k34062mfsf8bhbrckjh75213r9